Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...
5d
Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...
Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer ...
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...
After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...
For the full year, that translated into $175.2 billion in revenue for Elevance (a 2.9% increase over 2023), while profit hit ...
In a call with investors, CEO Gail Boudreaux didn’t directly address the killing of UnitedHealthcare’s top executive but spent more time than usual arguing Elevance is working to improve healthcare.
The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...
Elevance Health Inc (ELV) stock saw a decline, ending the day at $405.4 which represents a decrease of $-5.84 or -1.42% from the prior close of $411.24. The stock opened at $410.18 and touched a low ...
Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback